Aristeia Capital’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Aristeia Capital’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-375,000	Closed	-$3.86M	–	544
2022 Q4	$3.86M	Buy	375,000 +25,000	+7%	+$256K	0.08%	252
2022 Q3	$3.55M	Hold	350,000	–	–	0.06%	327
2022 Q2	$3.51M	Hold	350,000	–	–	0.06%	316
2022 Q1	$3.5M	Buy	+350,000	New	+$3.48M	0.06%	309

Aristeia Capital's THAC Position: Q1 2023 in Review

Aristeia Capital sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 375,000 shares — an estimated $3.86M sold.

Aristeia Capital first reported a position in THAC in Q1 2022 and held it in 4 quarters. The position peaked at $3.86M in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Aristeia Capital reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Aristeia Capital sold 375,000 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $3.86M.
Aristeia Capital first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q1 2022 and held it in 4 quarters.
Aristeia Capital's Thrive Acquisition Corporation Class A ordinary shares position peaked at $3.86M in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Aristeia Capital's 13F filing for Q1 2023, filed 16 May 2023.